The absence of ®ber regrowth in the injured spinal cord and brain is in¯uenced by several dierent factors and mechanisms. Among these are factors which inhibit neurite growth which are found on the surface of oligodendrocytes and central myelin. Their neutralization by a speci®c antibody allowed regeneration of transected corticospinal tract ®bers in the adult rat spinal cord. Using a recently introduced novel neuroanatomical tracer, biotin-dextran-amine, we demonstrate the extensive regenerative sprouting of lesioned corticospinal ®bers in the lesioned adult spinal cord. In the presence of the antibody against the myelin-associated neurite growth inhibitors, some of these ®bers grew over remaining tissue bridges into the caudal spinal cord. They branched extensively in the lumbar spinal cord segments. These branches were decorated with synapse-like boutons. This neuroanatomical con®guration probably contributes importantly to the functional recovery observed earlier in these antibody-treated animals.
Introduction
The irreversibility of the long-term functional de®cits resulting from spinal cord or brain lesions is largely due to the absence of regeneration of the lesioned axons. The cell biological reasons for this apparent inability of CNS ®ber tracts to regenerate have recently become a focus of interest for many research laboratories. Due to an enormous increase in our knowledge of the mechanisms regulating ®ber growth during nervous system development 1 and due to the availability of powerful new techniques (biochemistry, molecular biology, cell and tissue culture techniques, modern neuroanatomical tracing methods) important insights have been gained which have changed many of the traditional views. In this article we brie¯y review the present state of knowledge with regard to ®ber tract regeneration in the adult spinal cord (for an extensive review see 2 ) . We focus in particular on the work from our own laboratory, and we show new evidences for regenerative sprouting and ®ber growth using a novel, high resolution neuroanatomical tracer.
Adult nerve cells can reactivate a ®ber growth program following lesions
Early neuroanatomical as well as recent biochemical data show that neurons of the adult spinal cord or brain can re-enter a ®ber growth state following an axonal lesion. 2, 3 In an extensive series of experiments using transplants of peripheral nerves into the adult spinal cord or brain abundant ®ber ingrowth from CNS neurons into these transplants was shown.
± 6
These regenerating axons originate from projection neurons or from interneurons and can grow within these transplants for up to several centimeters. Genes associated with ®ber growth, in particular those for the cytoskeletal protein tubulin and the growth-associated protein GAP-43 are highly expressed in nerve cells during ®ber growth in development and downregulated to low levels in the adult. Both these genes are reactivated in dierent types of CNS neurons following axonal lesions. 2,7 ± 9 This activation of the cellular growth program is transitory. If axons do not ®nd a growth-permissive territory, eg a peripheral nerve transplant, growth-associated genes are downregulated, and the neurons often go into an atrophic state. If the axonal lesion is very close to the cell body, many neurons eventually die. Several of the recently discovered neurotrophic factors can rescue these lesioned neurons if applied into the CNS of experimental animals. 10, 11 Lesioned adult axons grow sprouts in response to injury growth-speci®c genes in the cell body. In adult rats with bilateral transections of the dorsal half of the spinal cord, including both corticospinal tracts, we have shown an increase in branch density rostral to the lesion 2 ± 3 weeks after transection. 12, 13 Whereas the tracer available at that time (wheat germ agglutinin coupled to horseradish peroxidase, WGA-HRP) did not allow single ®ber resolution, the introduction of a highly sensitive high resolution anterograde tracer, biotin-dextran-amine (BDA) now allows the visualization of this sprouting process in great detail.
14 Spinal cords of young adult (4 ± 6 week old) rats were transected at the midthoracic (T8) level in the dorsal half bilaterally 12 and BDA was injected into the sensory motor cortex. In addition, IN-1 antibodyproducing hybridoma cells (see below) were implanted. Two weeks later the animals were ®xed by transcardial perfusion, the spinal cord cut serially in the sagittal plane and processed histochemically.
14 Black reaction product marks the labelled corticospinal ®bers. As shown in Figure 1a the corticospinal tract (CST) approaches the lesion from rostral and sprouts extensively. Dense arborizations arising sometimes from single ®bers are apposed to the interface of the debris zone, the future cavern wall.
The mechanisms inducing and regulating this regenerative sprouting are not clear at present. Due to the lesions, massive changes in the tissue surrounding the trauma area take place, including an activation of astrocytes and microglia and in®ltration with in¯ammatory cells. 2, 15 Cytokines are synthesized locally, 16 ± 18 ®broblast growth factor (FGF) 19 and transforming factor beta (TGF-beta) 20 are expressed and changes in neurotrophins and their receptors also occur. 21, 22 Upregulation of growth-promoting substrates and possible downregulations of growth inhibitors in this perilesion area remain to be studied in detail. 23 This initial regenerative attempt of the lesioned axons is of transitory nature; sprouts and also the original axons often retract within 1 ± 2 months following the lesion. In the case of large lesions of the rat CST the retraction distance is 1 ± 2 mm from the lesion site.
12,24

Scars as barriers to axon growth
The inhibitory eect of caverns and large lesion scars has been observed early in studies on spinal cord and brain lesions. 3, 25, 26 The typical situation suggesting a local inhibitory interaction can also be seen in our experiments, eg in the spinal cord shown in Figure 1c . The underlying biochemical mechanisms are largely unknown. The fact that growing nerve ®bers are able to penetrate even dense astrocytic scars eg in amphibian optic nerves 27 or in vitro 28 argues against a purely mechanical eect. Proteins and proteoglycans with growth-inhibitory actions have been described in scar areas, 29 ± 31 but their direct involvement in growth inhibition at scars in vivo has not been shown yet.
Although caverns and scars are an important aspect of CNS and in particular spinal cord lesions, the typical contusion lesions often leave peripheral tissue bridges intact, both in experimental models as well as in paraplegic patients. 32 ± 34 As shown below, regenerating axons often use these tissue bridges to circumvent the lesion site.
Regenerating axons bypass the lesion but do not spontaneously elongate over long distances
Reconstructions of lesioned spinal cords with identi®ed tracts, eg the CST, frequently show sprouting axons growing around the lesion site on intact tissue bridges. In the animal model frequently used in our laboratory (bilateral transection of dorsal spinal cord) regenerating CST axons cross the lesion site in the ventral or ventrolateral gray or white matter (Figure 1a) . 12, 13, 35 When we measured the longest distance of regeneration in control animals (no antibody or control antibody treatments), a maximal distance of regeneration of 0.2 ± 1.2 mm with very rare examples up to 1.8 mm were seen (adult rats). 12, 13, 35 Similar results have been observed in dierent experimental models and species (mammals) (for review see 2 ). This suggests that additional inhibitory factors are present in the adult spinal cord tissue which prevent the elongation and long-distance regeneration of those ®bers which managed to circumvent the lesion and the scar. Potent neurite growth inhibitory activity has, indeed, been found in the myelin and the oligodendrocyte plasma membranes of the adult rat spinal cord and brain. 36 The biochemical analysis has given evidence for a new, high molecular weight membrane protein (neurite growth inhibitor NI-250) which is present in rat, bovine and human CNS myelin. 36 ± 38 The factor leads to rapid collapse and paralysis of neuritic growth cones by the activation of an intracellular signal cascade. 39 Antisera and in particular a monoclonal antibody (inhibitor neutralizing antibody IN-1) were shown to neutralize this myelin-associated neurite growth inhibitory activity in several cell and tissue assays. 39, 40 Antibodies against myelin-associated neurite growth inhibitors allow long-distance regeneration of lesioned adult corticospinal axons
In several series of experiments performed in rats neutralizing monoclonal antibodies against the myelinassociated neurite growth inhibitors described above (mAB IN-1) were applied to spinal cord lesioned animals. 12, 13, 35 When corticospinal axons were traced from the sensory-motor cortex 2 ± 6 weeks after the lesion, a mean of 5 ± 10% of the CST axons were observed in the segments of the spinal cord caudal to the lesion. Regeneration distances varied from animal to animal between 2.5 and 20 mm. Control animals (no antibodies or control antibodies against an unrelated protein (horseradish peroxidase) showed regeneration distances of 0.2 ± 1.8 mm. The concomitant adminis-tration of the neurotrophic factor neurotrophin 3 (NT-3) increased the sprouting and regeneration response of the lesioned CST axons. 35 Behavioural studies of these antibody-treated rats showed a very large degree of functional recovery for locomotion and for the corticospinally mediated placing response. 41 In contrast, the error rate (foot falls, hindlimb) during crossing of the rats on a grid did not improve in the IN-1 antibody-treated animals. Whether the number or type of regenerating ®bers were not sucient to restore this behaviour remains to be determined. mAB IN-1 has also been shown to enhance the plasticity of unlesioned axons in response to local deafferentations. 42, 43 Thus, enhanced plasticity may also contribute, probably in addition to and in collaboration with regenerating ®bers, to the improved functions observed in this behavioural study.
The detailed anatomy of regenerating ®bers could only be studied recently due to the availability of the new tracer BDA (see above). The same 1 ± 2 month old rats with partial, dorsal spinal cord transections at T8 described above were analysed for regenerating corticospinal ®bers 2 weeks after the lesion. Control rats (no antibody or control antibody) did not show CST axons at distances larger than 1.5 mm caudal to the transection site. In contrast, many of the rats treated with mAB IN-1 showed long-distance regeneration; some animals had CST ®bers at 10 ± 15 mm caudal from the transection (lower lumbar spinal cord). Figure 1a shows CST ®bers crossing the lesion site in the ventral gray matter (in rats, the CST is located in the dorsal funiculus!). Typically, these ®bers show an irregular course with frequent branching and direction changes. Some ®bers also grow in the ventral white matter. Regenerating CST axons reach the lower spinal segments by growing in the ventral or ventrolateral funiculus, through the gray matter, or, in about a third of the cases, by growing back into their original dorsal CST position.
A crucial question was whether these regenerated CST axons innervate spinal targets. The detailed analysis of these ®bers caudal to the lesion shows that they send branches into the gray matter at various levels. These branches form terminal arbors; often equipped with typical swellings which probably correspond to synaptic boutons (Figure 1b) . Integration of these regenerated axons into spinal circuits probably forms the basis for the functional recovery described above.
In Figure 1c , is the appearance of a control nonantibody treated cord for comparison. 
Alternative strategies: bridges and neurotrophic factors
To circumvent the scars and their barrier eect and to approach the long-term goal of enhancing regeneration also in cases of very large spinal cord lesions, attempts were made by several laboratories to directly bridge the lesion site. Implants of embryonic tissue have been used extensively and successfully in neonatal rat and cat spinal cord lesions 44, 45 and (for review see 2 ). In adult animals, the neuroanatomical analysis shows limited ingrowth of descending tracts into the transplants, but no real bridge function. 44 Important results were also obtained with peripheral nerve transplants used as bridges in rats with complete spinal cord transections. 4 Signi®cant numbers of axons entered these bridges, a result which can be enhanced by the simultaneous administration of neurotrophic factors. 46, 47 In a recent study with a very sophisticated neurosurgical approach up to 18 individual peripheral nerves were transplanted from white to gray matter areas following removal of a 5 mm segment of lower thoracic spinal cord. 48 Descending tract axons grew through these bridges and reinnervated the lumbar spinal cord. Very signi®cant improvements in hindlimb motor coordination were observed.
Members of several families of neurotrophic factors have been described mainly in the context of studies of nervous system development. 10, 49, 50 Infusions of some of these factors or local implantation of ®broblasts producing these factors from a transgene have been analysed in spinal cord lesions. 51, 52 Enhanced sprouting and growth of axons were found. Experiments using combinations of neurotrophic factors, antibodies against neurite growth inhibitors and also bridge implantations are on the way in several laboratories at present.
Outlook
The most important aspect of the current status of experimental spinal cord research is probably the fact that the dogma of the inability of CNS axons to regenerate no longer exists. Due to this, many research groups worldwide are now focussing their interest on the mechanisms involved in inducing and sustaining regeneration of lesioned axons in the spinal cord and brain. CNS lesions and regeneration have become central topics of current neurobiology, and the interaction and collaboration between the leading laboratories is intense. Combined approaches using stimulators of ®ber growth as well as blockers of the endogenous neurite growth inhibitory factors, together with treatments which minimize the tissue loss and bridges which improve the conditions for regenerating ®bers at the lesion site will clearly lead to regeneration of descending and ascending tract ®bers in the spinal cord and to signi®cant functional recovery in dierent animal models. The high similarity between mammals and man on the level of basic biological mechanisms including eg. neurotrophic factors and neurite growth inhibitors justi®es the hope that these developments will also lead to novel therapeutical strategies for spinal cord injured patients in the future.
